Skip to main content
SpringerLink
Log in

Conclusions

  • Chapter
Clinical Applications of Immunotoxins

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 234))

Abstract

The targeted toxin research reviewed in this volume includes recent advances in clinical applications of these compounds. The observation of clinical efficacy of both transferrin conjugated to mutant diphtheria toxin in high-grade gliomas and truncated diphtheria toxin fused to interleukin-2 in cutaneous T cell lymphomas and psoriasis are achievements for which all the members of the targeted toxin research community can be proud. The participation of so many colleagues in this field in this book has been a reflection both of the kindness and friendliness of the individuals as well as their commitment to working together to develop a new class of human therapeutics.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bookman M, Godfrey S, Padavic K, Griffin T, Corda J, Hamilton T, Ozols R, Groves E (1990) Antitransferrin receptor immunotoxin (IT) therapy: phase I intraperitoneal (i.p.) Trial. Proc Am Soc Clin Oncol 9: 187

    Google Scholar 

  • Capizzi RL (1996) Amifostine: the preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies. Semin Oncol 23: 2–17

    PubMed  CAS  Google Scholar 

  • Duvic M, Cather J, Maize J, Frankel AE (1997) DAB389IL2 diphtheria fusion toxin produces clinical responses in tumor stage cutaneous T cell lymphoma. Lancet (submitted)

    Google Scholar 

  • Falini B, Bolognesi A, Flenghi L, Tazzari P, Broe M, Stein H, Durkop H, Aversa F, Correli P, Pizzolo G, Barbabietola G, Sabattini E, Pileri S, Martelli M, Stirpe F (1992) Response of refractory Hodgkin’s disease to monoclonal anti-CD30 immunotoxin. Lancet 339: 1–5

    Article  Google Scholar 

  • Fischer A, Blanche S, Le Bidois J, Bordigoni P, Gamier J, Niaudet P (1991) Anti-B cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 324: 1451–1456

    Article  PubMed  CAS  Google Scholar 

  • Frankel AE, Tagge EP, Willingham MC (1995) Clinical trials of targeted toxins. Semin Cancer Biol 6: 307–317

    Article  PubMed  CAS  Google Scholar 

  • Frankel AE, Laver J, Willingham MC, Burns L, Kersey J, Vallera DA (1997) Therapy of patients with T-cell lymphomas using an anti-CD7 monoclonal antibody-ricin A chain immunotoxin. Leuk Lymph (in press)

    Google Scholar 

  • Ghetie M, Tucker K, Richardson J, Uhr J, Vitetta E (1994) Eradication of minimal disease in severe combined immunodeficient mice with disseminated Daudi lymphoma using chemotherapy and an immunotoxin cocktail. Blood 84: 702–707

    PubMed  CAS  Google Scholar 

  • Gould B, Borowitz M, Groves E, Carter P, Anthony D, Weiner J, Frankel A (1989) A phase I study of a continuous infusion anti-breast cancer immunotoxin: report of a targeted toxicity not predicted by animal studies. JNCI 81: 774–781

    Google Scholar 

  • Grossbard M, Freedman A, Ritz J, Coral F, Goldmacher V, Eliseo L, Spector N, Dear K, Lambert J, Blattler W, Taylor J, Nadler L (1992) Serotherapy of B-cell neoplasms with anti-B4-blocked ricin. A phase I trial of daily bolus infusion. Blood 79: 576–582

    Google Scholar 

  • Holloway KB (1992) Therapeutic alternatives in cutaneous T-cell lymphoma. J Am Acad Dermatol 27: 367–378

    Article  PubMed  CAS  Google Scholar 

  • Jansen B, Kersey J, Jaszcz W, Gunther R, Nguyen D, Chelstrom L, Tuelahlgren L, Uckun F (1993) Effective immunochemotherapy of human t(4;11) leukemia in mice with severe combined immunodeficiency (SCID) using B43 (anti-CDI9)-pokeweed antiviral protein immunotoxin plus cyclophosphamide. Leukemia 7: 290–297

    PubMed  CAS  Google Scholar 

  • Lidor Y, O’Briant K, Xu F, Hamilton T, Ozols R, Bast R (1993) Alkylating agents and immunotoxins exert synergistic cytotoxic activity against ovarian cancer cells. J Clin Invest 92: 2440–2447

    Article  PubMed  CAS  Google Scholar 

  • Liu C, Lambert J, Teicher B, Blattler W, O’Connor R (1996) Cure of multidrug-resistant human B-cell lymphoma xenografts by combinations of anti-B4-blocked ricin and chemotherapeutic drugs. Blood 87: 3892–3898

    PubMed  CAS  Google Scholar 

  • Loughran TP (1993) Clonal diseases of large granular lymphocytes. Blood 82: 1–14

    PubMed  Google Scholar 

  • O’Connor R, Liu C, Ferris C, Guild B, Teicher B, Corvi C, Liu Y, Arceci R, Goldmacher V, Lambert J, Blattler W (1995) Anti-B4-blocked ricin synergizes with doxorubicin and etoposide on multidrugresistant and drug-sensitive tumors. Blood 86: 4286–4294

    PubMed  Google Scholar 

  • Pai L, Bookman M, Ozols R, Young R, Smith J, Longo D, Gould B, Frankel A, McClay E, Howell S, Reed E, Willingham M, FitzGerald D, Pastan I (1991) Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer. J Clin Oncol 9: 2095–2102

    PubMed  CAS  Google Scholar 

  • Pai LH, Wittes R, Setser A, Willingham MC, Pastan I (1996) Treatment of advanced solid tumors with immunotoxin LMB-I: an antibody linked to Pseudomonas exotoxin. Nature Med 2: 350–353

    Article  PubMed  CAS  Google Scholar 

  • Pastan 1H (1997) Tumor immunotoxins: technology closes in on potential. Adv Oncol 13: 3–9

    Google Scholar 

  • Pearson J, FitzGerald D, Willingham M, Wiltrout R, Pastan I, Longo D (1989a) Chemóinrmunotoxin therapy against a human colon tumor (HT-29) xenograft in nude mice. Cancer Res 49: 3562–3567

    PubMed  CAS  Google Scholar 

  • Pearson J, Sivam G, Manger R, Wiltrout R, Morgan A, Longo D (1989b) Enhanced therapeutic efficacy of an immunotoxin in combination with chemotherapy against an intraperitoneal human tumor xenograft in athymic mice. Cancer Res 49: 4990–4995

    PubMed  CAS  Google Scholar 

  • Senderowicz AM, Vitetta E, Headlee D, Ghetie V, Uhr JW, Figg WD, Lush RM, Stetler-Stevenson M, Kershaw G, Kingma DW, Jaffe ES, Sausville EA (1997) Complete sustained response of a refractory, post-transplantation, large B-cell lymphoma to an anti-CD22 immunotoxin. Ann Intern Med 126: 882–885

    PubMed  CAS  Google Scholar 

  • Soler-Rodriguez A, Ghetie M, Oppenheimer-Marks N, Uhr J, Vitetta E (1993) Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: implications for vascular leak syndrome. Exp Cell Res 206: 227–234

    Article  PubMed  CAS  Google Scholar 

  • Strom T, Kelley V, Murphy J, Nichols B, Woodworth T (1994) Interleukin-2 receptor-directed therapies: antibody-or cytokine-based targeting molecules. Adv Nephrol 23: 347–356

    CAS  Google Scholar 

  • Uckun FM (1993) Immunotoxins for the treatment of leukaemia. Br J Haematol 85: 435–438

    Article  PubMed  CAS  Google Scholar 

  • Uckun F, Gajl-Peczalska K, Myers D, Ramsay N, Kersey J, Colvin M, Vallera D (1987) Marrow purging in autologous bone marrow transplantation for T-lineage acute lymphoblastic leukemia: efficacy of ex vivo treatment with immunotoxins and 4-hydroperoxy-cyclophosphamide against fresh leukemic marrow progenitor cells. Blood 69: 361–366

    PubMed  CAS  Google Scholar 

  • Weil-Hillman G, Uckun F, Manske J, Vallera D (1987) Combined immunochemotherapy of human solid tumors in nude mice. Cancer Res 47: 579–585

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hollings Cancer Center, 171 Ashley Avenue, 29425-2850, Charleston, SC, USA

    A. E. Frankel & M. C. Willingham

Authors
  1. A. E. Frankel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. C. Willingham
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hollings Cancer Center, Medical University of South Carolina, 171 Ashley Avenue, 29425-2850, Charleston, SC, USA

    Arthur E. Frankel M.D. (Associate Professor of Medicine) (Associate Professor of Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Frankel, A.E., Willingham, M.C. (1998). Conclusions. In: Frankel, A.E. (eds) Clinical Applications of Immunotoxins. Current Topics in Microbiology and Immunology, vol 234. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72153-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72153-3_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-72155-7

  • Online ISBN: 978-3-642-72153-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation